Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TheraBreath is a prominent consumer healthcare brand specializing in premium oral care products designed to address halitosis, dry mouth, and gum health. Founded in 1993 by Dr. Harold Katz, the company pioneered the use of stabilized chlorine dioxide (OXYD-8) to neutralize sulfur-producing bacteria rather than simply masking odors with alcohol or artificial flavors. Its product line includes a variety of mouthwashes, toothpastes, and specialty lozenges that are widely distributed in major retail chains globally. In 2021, the brand was acquired by Church & Dwight for $580 million, integrating it into a major portfolio of household and personal care products. TheraBreath remains a leader in the clinical oral care segment, emphasizing alcohol-free and vegan-friendly formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraBreath.